National law firm Foot Anstey has advised Prescient, a strategic partner to the biopharmaceutical industry backed by Bridgepoint, on its acquisition of London‑based pricing and market access consultancy Dolon Ltd, expanding Prescient’s specialist capabilities across the drug lifecycle. Dolon operates internationally and provides advisory expertise on market access, pricing and reimbursement strategies for rare diseases […]